Stockreport
Analysts consider potential Qiagen deal amid reported strategic review [Yahoo! Finance]
Last hologic, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.hologic.com
sale amid renewed interest from several global strategic buyers. The news sparked an immediate rally in the stock, as investors priced in a long-awaited consolidation. Analysts across Wall Street weighed in on the potential sale of the mid-cap diagnostics firm, following years of speculation about its future. Following the news, JPMorgan analyst Casey Woodring noted that "QGEN's profile shares similarities with HOLX's," referencing Hologic Inc (NASDAQ:HOLX), a women's health specialist that recently agreed to a private equity buyout. That deal carried a 46% premium over Hologic's unaffected share price, highlighting the high value placed on diagnostic platforms with stable, recurring cash flows Woodring suggested that Danaher Corporation (NYSE:DHR) and Agilent Technologies Inc (NYSE:A) screen as the most likely suitors due to their flexibility in pursuing large-scale transactions. Elsewhere, Wolfe Research analyst Doug Schenkel indicated that a deal now seems more feasible as
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | HOLX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
HOLX alerts
HOLX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
HOLX alerts
High impacting Hologic, Inc. news events
Weekly update
A roundup of the hottest topics
HOLX
NEWS
NEWS
- Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio[Business Wire]
- HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash [Yahoo! Finance][Yahoo! Finance]
- Hologic (NASDAQ:HOLX) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.[MarketBeat]
- Hologic Announces Financial Results for First Quarter of Fiscal 2026[Business Wire]
- Hologic, Inc. (HOLX): A Bear Case Theory [Yahoo! Finance][Yahoo! Finance]
- More
HOLX
SEC Filings
SEC Filings
- 2/12/26 - Form 4
- 2/6/26 - Form 8-K
- 2/3/26 - Form 4/A
- HOLX's page on the SEC website
- More